Furthermore, increased endothelin-1 (ET-1) levels in COPD patients, especially during exacerbations, contribute to pulmonary hypertension by promoting vasoconstriction and vascular remodeling [30,31,32]. The gene discussed is EDN1; the disease is pulmonary hypertension.